Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses
Xuenian Chen, Tongfei Shi, Chao Yang, Fangman Chen, Xuan He, Kunbao Zhang, Hanze Hu, Lulu Cai, Kam W. Leong, Dan Shao
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakImmune systemVirologySars virusComputational biologyBiologyCoronavirus InfectionsImmunologyMedicinePathologyInfectious disease (medical specialty)OutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchNanoplatforms for cancer theranosticsBacteriophages and microbial interactions